Aengus Ó Snodaigh (Dublin South Central, Sinn Fein) | Oireachtas source

Since this committee is not an expert committee, I suggest that we write to the Irish Medicines Board specifically to find out its procedures in authorising new drugs coming onto the market and to establish the steps it takes to monitor continually the adverse effects of drugs that are on sale. When it is established that there are serious adverse effects, how is a drug withdrawn from the market? What plateau must be reached before a drug is refused a licence for the Irish market?